GISEV Family Office is an independent multi-family office based in Lugano, Switzerland, founded in 2017. The firm provides strategic consulting, family governance, integrated asset consolidation, and wealth management services, with investment activities spanning real estate, venture capital, and early-stage companies across sectors such as biotech, agriculture, and consumer health.
Their most common stage is series-a (43% of deals). Average disclosed round size is $19.3M (across 11 rounds with reported amounts).
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
MA
Matteo Alicanti
Investment Director
SS
Stefano Secco
Strategic Investment Officer
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| SSyocin | Seed | — | Mar 2022 |
 Symbiome | Series A | $8M | Jan 2021 |
 Manual.to | Seed | $30M | Jan 2021 |
| Manual.to | Series A | $30M | Jan 2021 |
 Solarea Bio | Series A | $11.2M | Oct 2020 |
 Shampora | Growth | — | Jan 2020 |
| Symbiome | Series A | $8M | Jan 2020 |
| Solarea Bio | Series B | $11.2M | Jan 2020 |
 Elysium Health | Series C | $40M | Dec 2019 |
| Symbiome | Series A | $8M | Jan 2019 |
| Elysium Health | Series C | $40M | Jan 2019 |
| Symbiome | Pre-Seed | $15M | Jan 2017 |
| SSyocin Biotech | Seed | — | — |
| Solarea Bio | Series A | $11.2M | — |
Top Co-Investors
Bold Capital Partners7 shared
True Ventures4 shared
S2G Ventures3 shared
Viking Global3 shared
Mission BioCapital2 shared
Cherry Ventures2 shared
Sonoma Brands Capital2 shared
Felix Capital2 shared
FJ Labs2 shared
Blue Horizon2 shared
Rough Draft2 shared
General Catalyst2 shared
Breyer Capital2 shared
Western Technology Investment2 shared
Mayo Clinic Ventures2 shared
Morningside Ventures2 shared
J.P. Morgan1 shared
Seeder Fund1 shared
CASSIUS1 shared
Waldencast1 shared
Last updated: 27 September 2026